SCSC vs. MRK
SCSC (ScanSource, Inc.) and MRK (Merck & Co., Inc.) are both stocks. SCSC operates in Electronics & Computer Distribution (Technology), while MRK operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SCSC returned 3.46%/yr vs 12.26%/yr for MRK. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
SCSC vs. MRK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SCSC achieves a 44.96% return, which is significantly higher than MRK's 25.51% return. Over the past 10 years, SCSC has underperformed MRK with an annualized return of 3.46%, while MRK has yielded a comparatively higher 12.26% annualized return.
SCSC
- 1D
- 0.25%
- 1M
- 11.30%
- 6M
- 31.71%
- YTD
- 44.96%
- 1Y
- 49.87%
- 3Y*
- 23.58%
- 5Y*
- 15.46%
- 10Y*
- 3.46%
- ALL TIME*
- 9.23%
MRK
- 1D
- 0.32%
- 1M
- 0.49%
- 6M
- 19.80%
- YTD
- 25.51%
- 1Y
- 69.70%
- 3Y*
- 10.70%
- 5Y*
- 14.64%
- 10Y*
- 12.26%
- ALL TIME*
- 12.54%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $997.19M | $1.08B | $1.21B | |
SCSC ScanSource, Inc. | $10.31M | $9.78M | $11.14M |
SCSC vs. MRK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SCSC ScanSource, Inc. | 44.96% | -17.68% | 19.79% | 35.56% | -16.70% | 32.98% | -28.61% | 7.48% | -3.97% | -11.28% |
MRK Merck & Co., Inc. | 25.51% | 9.79% | -6.26% | 1.01% | 49.42% | 1.75% | -7.20% | 22.27% | 39.95% | -1.49% |
Correlation
The correlation between SCSC and MRK is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.02 |
Correlation (3Y) Balances recent behavior with more history. | 0.09 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.07 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.14 |
Correlation (All Time) Calculated using the full available price history since Mar 18, 1994 | 0.17 |
The correlation between SCSC and MRK shifts across timeframes, from 0.02 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.
Fundamentals
SCSC:
$1.15B
MRK:
$321.62B
SCSC:
$3.33
MRK:
$3.59
SCSC:
17.01
MRK:
36.23
SCSC:
0.83
MRK:
0.03
SCSC:
0.40
MRK:
4.93
SCSC:
1.35
MRK:
7.02
SCSC:
$3.09B
MRK:
$65.59B
SCSC:
$416.89M
MRK:
$49.79B
SCSC:
$122.21M
MRK:
$22.69B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SCSC vs. MRK — Risk / Return Rank
SCSC
MRK
SCSC vs. MRK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ScanSource, Inc. (SCSC) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SCSC | MRK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.44 | ||
| Sortino ratioReturn per unit of downside risk | -2.07 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.44 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.88 | 6.39 | -4.51 |
| Martin ratioReturn relative to average drawdown | 4.29 | 16.11 | -11.82 |
Loading charts...
Drawdowns
SCSC vs. MRK - Drawdown Comparison
The maximum SCSC drawdown since its inception was -76.88%, which is greater than MRK's maximum drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for SCSC and MRK.
Loading charts...
Drawdown Indicators
| SCSC | MRK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.88% | -68.61% | -8.27% |
Max Drawdown (1Y)Largest decline over 1 year | -24.52% | -11.37% | -13.15% |
Max Drawdown (3Y)Largest decline over 3 years | -44.21% | -43.44% | -0.77% |
Max Drawdown (5Y)Largest decline over 5 years | -44.21% | -43.44% | -0.77% |
Max Drawdown (10Y)Largest decline over 10 years | -67.54% | -43.44% | -24.10% |
Current DrawdownCurrent decline from peak | -1.32% | -1.23% | -0.09% |
Average DrawdownAverage peak-to-trough decline | -21.78% | -18.79% | -2.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.70% | 4.50% | +6.20% |
Volatility
SCSC vs. MRK - Volatility Comparison
The current volatility for ScanSource, Inc. (SCSC) is 7.66%, while Merck & Co., Inc. (MRK) has a volatility of 8.23%. This indicates that SCSC experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SCSC | MRK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.66% | 8.23% | -0.57% |
Volatility (6M)Calculated over the trailing 6-month period | 30.30% | 19.68% | +10.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.23% | 27.87% | +10.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.81% | 24.10% | +12.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.90% | 23.13% | +16.77% |
Dividends
SCSC vs. MRK - Dividend Comparison
SCSC has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 2.58%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 2.58% | 3.12% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% |
SCSC ScanSource, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SCSC vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between ScanSource, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SCSC vs. MRK - Profitability Comparison
SCSC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, ScanSource, Inc. reported a gross profit of 107.12M and revenue of 766.79M. Therefore, the gross margin over that period was 14.0%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.
SCSC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, ScanSource, Inc. reported an operating income of 23.12M and revenue of 766.79M, resulting in an operating margin of 3.0%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.
SCSC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, ScanSource, Inc. reported a net income of 16.89M and revenue of 766.79M, resulting in a net margin of 2.2%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.
Frequently Asked Questions
SCSC and MRK have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRK has higher volatility (8.23%) compared to SCSC (7.66%). In terms of maximum drawdown, SCSC dropped -76.88% vs MRK's -68.61%.
MRK currently has the higher Sharpe Ratio (2.64 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SCSC and MRK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer